Recent market volatility could be a precursor to more sell-offs in the near term, according to Muzinich & Co founder George Muzinich.

Recent market volatility could be a precursor to more sell-offs in the near term, according to Muzinich & Co founder George Muzinich.
Index providers are labelling growth and value stocks seemingly arbitrarily, according to GMO’s asset allocation team.
FSA highlights five top-ranked Japanese equity funds that were least affected by the Japanese market volatility.
Portfolio managers at AllianceBernstein think investors are under-reacting to cash earnings power of value companies.
It will invest primarily in short duration US Treasuries and investment-grade bonds.
The Fed is more likely to normalise monetary policy instead of aggressively cutting rates, says AXA Investment Manager’s Asia CIO Ecaterina Bigos.
The asset manager’s biotech portfolio managers see a strong setup for biotech stocks in the coming quarters.
FSA looks at how gold funds available for distribution in Hong Kong and Singapore are performing as gold prices rally past all-time highs.
“We want to justify the fee we earn from clients,” Anand Gupta tells FSA in an interview.
FSA highlights five global equity funds with top ranked performance year-to-date after outperforming in 2023.
Part of the Mark Allen Group.